Racial disparity in efficacy of docosahexaenoic acid supplementation for prevention of preterm birth: secondary analysis from a randomized, double-blind trial

Funding

This study was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (grant number: R01HD083292). S.E.C., B.J.G. and C.J.V. were principal investigators (PIs), and E.A.D. is a site PI of the multisite trial conducted under grant number R01HD083292; S.E.C. has received honorariums for presentations about docosahexaenoic acid (DHA) in infancy and pregnancy; C.J.V. was an employee of RB Nutrition, which produces infant formulas and supplements with DHA at the time the study was conducted; however, RB Nutrition was not involved in the study execution or analysis. C.J.V. conducted this study through her role as an adjunct professor at the University of Cincinnati. The other authors report no conflict of interest.